Caplin Point Laboratories Ltd has delivered a return of 23.24% over the last 3 months. The stock was trading at ₹2,077.90 on 25 May 2026 and is currently at ₹2,487.50 as of 24 Aug 2026, reflecting a Gain of ₹409.60 per share over this period.

Yes,Caplin Point Laboratories Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 27.50 per share between FY2022 and FY2026, with the most recent dividend of ₹4.00 per share for Aug 26, with an ex-dividend date of 18 Sep 2026. At the current market price of ₹2,487.50, the trailing dividend yield of Caplin Point Laboratories Ltd stands at 10.00%.

Caplin Point Laboratories Ltd has delivered a 244.45% absolute return over the past 5 years, equivalent to a CAGR of 28.06% per annum. The stock was priced at ₹722.17 in Aug 2021 and has risen to ₹2,487.50 as of 24 Aug 2026. An investment of ₹1,00,000 in Caplin Point Laboratories Ltd five years ago would be worth ₹3,44,450.00 today.

The all-time high (ATH) for Caplin Point Laboratories Ltd was ₹2,671.50, recorded on 16 Jul 2026. At the current price of ₹2,487.50, the stock is trading 6.89% below its all-time high. The all-time low recorded was ₹35.64 on 24 Jun 2014.

Caplin Point Laboratories Ltd has delivered 18.43% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹2,699.00 on 15 Jul 2026 and a 52-week low of ₹1,500.30 on 30 Mar 2026. It is currently trading at ₹2,487.50 as of 24 Aug 2026.

As of 24 Aug 2026, the share price of Caplin Point Laboratories Ltd is ₹2,487.50 on the NSE and ₹2,489.10 on the BSE. The stock opened at ₹2,542.00, touched a high of ₹2,555.60 and a low of ₹2,473.90 during today's session.

Over the last 6 months, Caplin Point Laboratories Ltd has given a return of 49.53%. The stock was priced at ₹1,712.60 on 24 Feb 2026 and has Rise to ₹2,487.50 as of 24 Aug 2026, a change of ₹774.90 per share.

For Q1 FY27, Caplin Point Laboratories Ltd reported: Revenue (Net Sales): ₹2318.50 Cr - Up 21.16% year-on-year from ₹1913.60 Cr in Q4 FY26. Net Income (PAT): ₹1203.80 Cr - Up 9.94% year-on-year from ₹1095.00 Cr in Q4 FY26.

The intraday high for Caplin Point Laboratories Ltd on the NSE today (24 Aug 2026) was ₹2,555.60. This compares to the 52-week high of ₹2,699.00 recorded on 15 Jul 2026. Today's high was -5.31% below the 52-week high.

The intraday low for Caplin Point Laboratories Ltd on the NSE today was ₹2,473.90. The stock's 52-week low stands at ₹1,500.30, recorded on 30 Mar 2026. Today's low is 64.89% above the 52-week low, indicating the stock is trading well above its yearly lows.